A stem cell therapy aimed at helping patients recover from spinal cord injuries has been greenlit in Japan . By extracting mesenchymal stem cells from injured individuals , growing 50 - 200 million of them in the lab , and then intravenously injection them into the brain , Stemirac is meant to aid in patient recovery . After a small clinical trial , the decision was made to conditionally approve the method . However , specialists have raised concerns over the efficacy of the therapy . Little is known about how recovery is achieved by the treatment , and the findings of the unpublished clinical trial have been flagged as insufficient .
A stem cell therapy aimed at helping patients recover from spinal cord injuries has been greenlit in Japan. By extracting mesenchymal stem cells from injured individuals, growing 50-200 million of them in the lab, and then intravenously reintegrating them into the patient, Stemirac is meant to aid in injury recovery. After a small clinical trial, the decision was made to conditionally approve the method. However, specialists have raised concerns over the efficacy of the therapy. Little is known about how recovery is helped by the treatment, and the findings of the unpublished 13-person trial have been flagged as insufficient.